Header Logo

Connection

MICHAEL R MIGDEN to Adrenergic beta-Antagonists

Back to Details
This is a "connection" page, showing publications MICHAEL R MIGDEN has written about Adrenergic beta-Antagonists.
MICHAEL R MIGDEN
Connection Strength
0.185
Adrenergic beta-Antagonists
  1. Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer. JCO Precis Oncol. 2023 06; 7:e2200490.
    View in: PubMed
    Score: 0.185
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.